<DOC>
	<DOC>NCT02236728</DOC>
	<brief_summary>The primary objective of this study was to describe neurologists' population of patients treated with pramipexole and suffering from Parkinson's disease (so called 'primary care' population). The secondary objectives were: - Evaluate the mean dose of pramipexole prescribed under actual conditions of use depending on the severity of the disease. - Evaluate the reasons for choosing pramipexole as treatment. - Identify the patient profiles determining the choice of dose of pramipexole prescribed</brief_summary>
	<brief_title>Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Patients suffering from idiopathic Parkinson's Disease and treated with pramipexole for at least two months, examined in consultation Patient refusing to take part Patient taking part in a clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>